Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The auditory system of the goldfish (Carassius auratus): effects of intense acoustic stimulation.

Literature DB >> 176

The auditory system of the goldfish (Carassius auratus): effects of intense acoustic stimulation.

A N Popper, N L Clarke.

Abstract

Entities: Species

Mesh：

Year: 1976 PMID： 176 DOI： 10.1016/s0300-9629(76)80003-5

Source DB: PubMed Journal: Comp Biochem Physiol A Comp Physiol ISSN： 0300-9629

× No keyword cloud information.

18 in total

1. Statins and hepatic steatosis: perspectives from the Dallas Heart Study.

Authors: Jeffrey D Browning
Journal: Hepatology Date: 2006-08 Impact factor: 17.425

Review 2. From fat to inflammation.

Authors: Christopher Paul Day
Journal: Gastroenterology Date: 2006-01 Impact factor: 22.682

3. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients.

Authors: Giovanni Targher; Lorenzo Bertolini; Roberto Padovani; Stefano Rodella; Roberto Tessari; Luciano Zenari; Christopher Day; Guido Arcaro
Journal: Diabetes Care Date: 2007-02-02 Impact factor: 19.112

4. Hepatic histology in obese patients undergoing bariatric surgery.

Authors: Mariana Machado; Pedro Marques-Vidal; Helena Cortez-Pinto
Journal: J Hepatol Date: 2006-07-25 Impact factor: 25.083

5. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.

Authors: M J Contos; W Cales; R K Sterling; V A Luketic; M L Shiffman; A S Mills; R A Fisher; J Ham; A J Sanyal
Journal: Liver Transpl Date: 2001-04 Impact factor: 5.799

6. Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.

Authors: J Ong; Z M Younossi; V Reddy; L L Price; T Gramlich; J Mayes; N Boparai
Journal: Liver Transpl Date: 2001-09 Impact factor: 5.799

7. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C.

Authors: Arun J Sanyal; Colin Banas; Carol Sargeant; Velimir A Luketic; Richard K Sterling; Richard T Stravitz; Mitchell L Shiffman; Douglas Heuman; Adrian Coterrell; Robert A Fisher; Melissa J Contos; Alan S Mills
Journal: Hepatology Date: 2006-04 Impact factor: 17.425

8. Long-term follow-up of patients with NAFLD and elevated liver enzymes.

Authors: Mattias Ekstedt; Lennart E Franzén; Ulrik L Mathiesen; Lars Thorelius; Marika Holmqvist; Göran Bodemar; Stergios Kechagias
Journal: Hepatology Date: 2006-10 Impact factor: 17.425

9. Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis.

Authors: Jean-François Dufour; Carl M Oneta; Jean-Jacques Gonvers; Florian Bihl; Andreas Cerny; Jean-Michel Cereda; Jean-Franco Zala; Beat Helbling; Michael Steuerwald; Arthur Zimmermann
Journal: Clin Gastroenterol Hepatol Date: 2006-12 Impact factor: 11.382